{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:10:46Z","timestamp":1794964246490,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-17-C-0009"],"award-info":[{"award-number":["HDTRA1-17-C-0009"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transmission of Ebola virus (EBOV) primarily occurs via contact exposure of mucosal surfaces with infected body fluids. Historically, nonhuman primate (NHP) challenge studies have employed intramuscular (i.m.) or small particle aerosol exposure, which are largely lethal routes of infection, but mimic worst-case scenarios such as a needlestick or intentional release, respectively. When exposed by more likely routes of natural infection, limited NHP studies have shown delayed onset of disease and reduced mortality. Here, we performed a series of systematic natural history studies in cynomolgus macaques with a range of conjunctival exposure doses. Challenge with 10,000 plaque forming units (PFU) of EBOV was uniformly lethal, whereas 5\/6 subjects survived lower dose challenges (100 or 500 PFU). Conjunctival challenge resulted in a protracted time-to death compared to i.m. Asymptomatic infection was observed in survivors with limited detection of EBOV replication. Inconsistent seropositivity in survivors may suggest physical or natural immunological barriers are sufficient to prevent widespread viral dissemination.<\/jats:p>","DOI":"10.1038\/s41598-023-31027-7","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:03:03Z","timestamp":1678712583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Natural history of nonhuman primates after conjunctival exposure to Ebola virus"],"prefix":"10.1038","volume":"13","author":[{"given":"Robert W.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney B.","family":"Woolsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Dobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Ian","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla A.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"31027_CR1","volume-title":"Field's Virology","author":"H Feldmann","year":"2013","unstructured":"Feldmann, H., Sanchez, A. & Geisbert, T. W. Field\u2019s Virology Vol. 6 (Lippincott Williams & Wilkins, 2013)."},{"issue":"1721","key":"31027_CR2","doi-asserted-by":"publisher","first-page":"20160297","DOI":"10.1098\/rstb.2016.0297","volume":"372","author":"CE Coltart","year":"2017","unstructured":"Coltart, C. E. et al. The Ebola outbreak, 2013\u20132016: Old lessons for new epidemics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372(1721), 20160297 (2017).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"9","key":"31027_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1473-3099(19)30291-9","volume":"19","author":"LK McMullan","year":"2019","unstructured":"McMullan, L. K. et al. Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: A phylogenetic and in vitro analysis. Lancet Infect. Dis. 19(9), 1023\u20131032 (2019).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"31027_CR4","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1038\/s41598-022-09564-4","volume":"12","author":"H Vossler","year":"2022","unstructured":"Vossler, H. et al. Analysis of individual-level data from 2018\u20132020 Ebola outbreak in Democratic Republic of the Congo. Sci. Rep. 12(1), 5534 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"31027_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15252\/emmm.201404792","volume":"7","author":"A Mar\u00edSa\u00e9z","year":"2015","unstructured":"Mar\u00edSa\u00e9z, A. et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol. Med. 7(1), 17\u201323 (2015).","journal-title":"EMBO Mol. Med."},{"issue":"Suppl 3","key":"31027_CR6","doi-asserted-by":"publisher","first-page":"S796","DOI":"10.1093\/infdis\/jir312","volume":"204","author":"J Adjemian","year":"2011","unstructured":"Adjemian, J. et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J. Infect. Dis. 204(Suppl 3), S796\u2013S799 (2011).","journal-title":"J. Infect. Dis."},{"issue":"9","key":"31027_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJMoa051465","volume":"355","author":"DG Bausch","year":"2006","unstructured":"Bausch, D. G. et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N. Engl. J. Med. 355(9), 909\u2013919 (2006).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"31027_CR8","doi-asserted-by":"publisher","first-page":"e1002877","DOI":"10.1371\/journal.ppat.1002877","volume":"8","author":"BR Amman","year":"2012","unstructured":"Amman, B. R. et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 8(10), e1002877 (2012).","journal-title":"PLoS Pathog."},{"issue":"4","key":"31027_CR9","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/v6041759","volume":"6","author":"KJ Olival","year":"2014","unstructured":"Olival, K. J. & Hayman, D. T. Filoviruses in bats: current knowledge and future directions. Viruses 6(4), 1759\u20131788 (2014).","journal-title":"Viruses"},{"issue":"10","key":"31027_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/v10100549","volume":"10","author":"A Caron","year":"2018","unstructured":"Caron, A. et al. Ebola virus maintenance: If not (only) bats, what else?. Viruses 10(10), 549 (2018).","journal-title":"Viruses"},{"issue":"13","key":"31027_CR11","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa2024670","volume":"384","author":"P Mbala-Kingebeni","year":"2021","unstructured":"Mbala-Kingebeni, P. et al. Ebola virus transmission initiated by relapse of systemic Ebola virus disease. N. Engl. J. Med. 384(13), 1240\u20131247 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"7877","key":"31027_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","volume":"597","author":"AK Keita","year":"2021","unstructured":"Keita, A. K. et al. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. Nature 597(7877), 539\u2013543 (2021).","journal-title":"Nature"},{"issue":"2","key":"31027_CR13","first-page":"271","volume":"56","author":"WHO","year":"1978","unstructured":"WHO. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 56(2), 271\u2013293 (1978).","journal-title":"Bull World Health Organ."},{"issue":"5675","key":"31027_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.304.5675.1225b","volume":"304","author":"R Stone","year":"2004","unstructured":"Stone, R. Russian scientist dies after Ebola lab accident. Science 304(5675), 1225\u20131225 (2004).","journal-title":"Science"},{"issue":"Suppl 3","key":"31027_CR15","doi-asserted-by":"publisher","first-page":"S785","DOI":"10.1093\/infdis\/jir298","volume":"204","author":"S Gunther","year":"2011","unstructured":"Gunther, S. et al. Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 204(Suppl 3), S785\u2013S790 (2011).","journal-title":"J Infect Dis"},{"issue":"11","key":"31027_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/S1473-3099(15)00228-5","volume":"15","author":"M Jacobs","year":"2015","unstructured":"Jacobs, M. et al. Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: A case-series of health-care workers. Lancet. Infect. Dis 15(11), 1300\u20131304 (2015).","journal-title":"Lancet. Infect. Dis"},{"issue":"2","key":"31027_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4269\/ajtmh.14-0769","volume":"92","author":"L Rubinson","year":"2015","unstructured":"Rubinson, L. From clinician to suspect case: My experience after a needle stick in an Ebola treatment unit in Sierra Leone. Am. J. Trop. Med. Hyg. 92(2), 225\u2013226 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"suppl_3","key":"31027_CR18","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","volume":"214","author":"P Vetter","year":"2016","unstructured":"Vetter, P. et al. Ebola virus shedding and transmission: Review of current evidence. J. Infect. Dis. 214(suppl_3), S177\u2013S184 (2016).","journal-title":"J. Infect. Dis."},{"issue":"10","key":"31027_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/cid\/ciw123","volume":"62","author":"WA Fischer II","year":"2016","unstructured":"Fischer, W. A. II. & Wohl, D. A. Confronting Ebola as a sexually transmitted infection. Clin. Infect. Dis. 62(10), 1272\u20131276 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"31027_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2021.03.008","volume":"71","author":"O Tomori","year":"2021","unstructured":"Tomori, O. & Kolawole, M. O. Ebola virus disease: Current vaccine solutions. Curr. Opin. Immunol. 71, 27\u201333 (2021).","journal-title":"Curr. Opin. Immunol."},{"issue":"Suppl 2","key":"31027_CR21","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1093\/infdis\/jiv284","volume":"212","author":"TW Geisbert","year":"2015","unstructured":"Geisbert, T. W., Strong, J. E. & Feldmann, H. Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection. J. Infect. Dis. 212(Suppl 2), S91\u2013S97 (2015).","journal-title":"J. Infect. Dis."},{"issue":"6949","key":"31027_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nature01876","volume":"424","author":"NJ Sullivan","year":"2003","unstructured":"Sullivan, N. J. et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424(6949), 681\u2013684 (2003).","journal-title":"Nature"},{"issue":"11","key":"31027_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/v10110642","volume":"10","author":"K Alfson","year":"2018","unstructured":"Alfson, K. et al. Intramuscular exposure of Macaca fascicularis to low doses of low passage- or cell culture-adapted Sudan virus or Ebola virus. Viruses 10(11), 642 (2018).","journal-title":"Viruses"},{"issue":"13","key":"31027_CR24","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1128\/JVI.00649-15","volume":"89","author":"KJ Alfson","year":"2015","unstructured":"Alfson, K. J. et al. Particle to plaque-forming unit ratio of Ebola virus influences disease course and survival in cynomolgus macaques. J. Virol. 89(13), 6773\u20136781 (2015).","journal-title":"J. Virol."},{"issue":"suppl_5","key":"31027_CR25","doi-asserted-by":"publisher","first-page":"S582","DOI":"10.1093\/infdis\/jiy293","volume":"218","author":"C Woolsey","year":"2018","unstructured":"Woolsey, C. et al. Postexposure efficacy of recombinant vesicular stomatitis virus vectors against high and low doses of Marburg virus variant Angola in nonhuman primates. J. Infect. Dis. 218(suppl_5), S582\u2013S587 (2018).","journal-title":"J. Infect. Dis."},{"key":"31027_CR26","doi-asserted-by":"publisher","first-page":"709772","DOI":"10.3389\/fimmu.2021.709772","volume":"12","author":"SC Johnston","year":"2021","unstructured":"Johnston, S. C. et al. Delayed disease in cynomolgus macaques exposed to Ebola virus by an intranasal route. Front. Immunol. 12, 709772 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"31027_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/pathogens10030292","volume":"10","author":"T Brasel","year":"2021","unstructured":"Brasel, T. et al. Mucosal challenge ferret models of Ebola virus disease. Pathogens 10(3), 292 (2021).","journal-title":"Pathogens"},{"issue":"4","key":"31027_CR28","first-page":"227","volume":"76","author":"E Johnson","year":"1995","unstructured":"Johnson, E. et al. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 76(4), 227\u2013236 (1995).","journal-title":"Int. J. Exp. Pathol."},{"issue":"52","key":"31027_CR29","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","volume":"26","author":"TW Geisbert","year":"2008","unstructured":"Geisbert, T. W. et al. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine 26(52), 6894\u20136900 (2008).","journal-title":"Vaccine"},{"issue":"5","key":"31027_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/0300985810378597","volume":"47","author":"DA Alves","year":"2010","unstructured":"Alves, D. A. et al. Aerosol exposure to the Angola strain of Marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques. Vet. Pathol. 47(5), 831\u2013851 (2010).","journal-title":"Vet. Pathol."},{"issue":"11","key":"31027_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.micinf.2011.05.002","volume":"13","author":"DS Reed","year":"2011","unstructured":"Reed, D. S. et al. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: Differences in disease course and clinical pathology. Microbes Infect. 13(11), 930\u2013936 (2011).","journal-title":"Microbes Infect."},{"issue":"11","key":"31027_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/v9110319","volume":"9","author":"KJ Alfson","year":"2017","unstructured":"Alfson, K. J. et al. Development of a lethal intranasal exposure model of Ebola virus in the cynomolgus macaque. Viruses 9(11), 319 (2017).","journal-title":"Viruses"},{"issue":"2","key":"31027_CR33","first-page":"140","volume":"120","author":"NK Jaax","year":"1996","unstructured":"Jaax, N. K. et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med. 120(2), 140\u2013155 (1996).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"suppl 3","key":"31027_CR34","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1093\/infdis\/jiw149","volume":"214","author":"CE Mire","year":"2016","unstructured":"Mire, C. E. et al. Oral and conjunctival exposure of nonhuman primates to low doses of Ebola Makona virus. J. Infect. Dis. 214(suppl 3), S263\u2013S267 (2016).","journal-title":"J. Infect. Dis."},{"issue":"10","key":"31027_CR35","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3201\/eid2110.150259","volume":"21","author":"A Marzi","year":"2015","unstructured":"Marzi, A. et al. Delayed disease progression in cynomolgus macaques infected with Ebola virus Makona strain. Emerg. Infect. Dis. 21(10), 1777\u20131783 (2015).","journal-title":"Emerg. Infect. Dis."},{"issue":"6249","key":"31027_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aab3920","volume":"349","author":"A Marzi","year":"2015","unstructured":"Marzi, A. et al. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain. Science 349(6249), 739\u2013742 (2015).","journal-title":"Science"},{"key":"31027_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nature14428","volume":"520","author":"CE Mire","year":"2015","unstructured":"Mire, C. E. et al. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature 520, 688\u2013691 (2015).","journal-title":"Nature"},{"issue":"4","key":"31027_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/infdis\/jiy537","volume":"219","author":"A Patel","year":"2018","unstructured":"Patel, A. et al. Protective efficacy and long-term immunogenicity in cynomolgus macaques by Ebola virus glycoprotein synthetic DNA vaccines. J. Infect. Dis. 219(4), 544\u2013555 (2018).","journal-title":"J. Infect. Dis."},{"key":"31027_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ebiom.2019.09.055","volume":"49","author":"A Marzi","year":"2019","unstructured":"Marzi, A. et al. Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge. EBioMedicine 49, 223\u2013231 (2019).","journal-title":"EBioMedicine"},{"issue":"1","key":"31027_CR40","doi-asserted-by":"publisher","first-page":"9730","DOI":"10.1038\/s41598-017-09963-y","volume":"7","author":"K Versteeg","year":"2017","unstructured":"Versteeg, K. et al. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Sci. Rep. 7(1), 9730 (2017).","journal-title":"Sci. Rep."},{"issue":"2","key":"31027_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajic.2014.10.015","volume":"43","author":"YL Kwok","year":"2015","unstructured":"Kwok, Y. L., Gralton, J. & McLaws, M. L. Face touching: A frequent habit that has implications for hand hygiene. Am. J. Infect. Control 43(2), 112\u2013114 (2015).","journal-title":"Am. J. Infect. Control"},{"issue":"6","key":"31027_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15459620802003896","volume":"5","author":"M Nicas","year":"2008","unstructured":"Nicas, M. & Best, D. A study quantifying the hand-to-face contact rate and its potential application to predicting respiratory tract infection. J. Occup. Environ. Hyg. 5(6), 347\u2013352 (2008).","journal-title":"J. Occup. Environ. Hyg."},{"issue":"4","key":"31027_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0028-3932(86)90105-3","volume":"24","author":"SD Suarez","year":"1986","unstructured":"Suarez, S. D. & Gallup, G. G. Face touching in primates: A closer look. Neuropsychologia 24(4), 597\u2013600 (1986).","journal-title":"Neuropsychologia"},{"issue":"7","key":"31027_CR44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3201\/eid2107.150253","volume":"21","author":"R Fischer","year":"2015","unstructured":"Fischer, R. et al. Ebola virus stability on surfaces and in fluids in simulated outbreak environments. Emerg. Infect. Dis. 21(7), 1243\u20131246 (2015).","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"31027_CR45","first-page":"1531","volume":"109","author":"TJ Piercy","year":"2010","unstructured":"Piercy, T. J. et al. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J. Appl. Microbiol. 109(5), 1531\u20131539 (2010).","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"31027_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1067\/mai.2000.111029","volume":"106","author":"L Bielory","year":"2000","unstructured":"Bielory, L. Allergic and immunologic disorders of the eye. Part I: immunology of the eye. J. Allergy Clin. Immunol. 106(5), 805\u2013816 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"31027_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874364101509010049","volume":"9","author":"R Bolanos-Jimenez","year":"2015","unstructured":"Bolanos-Jimenez, R. et al. Ocular surface as barrier of innate immunity. Open Ophthalmol. J. 9, 49\u201355 (2015).","journal-title":"Open Ophthalmol. J."},{"key":"31027_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2013.00185","volume":"4","author":"B Corthesy","year":"2013","unstructured":"Corthesy, B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front. Immunol. 4, 185 (2013).","journal-title":"Front. Immunol."},{"issue":"4","key":"31027_CR49","first-page":"622","volume":"27","author":"PK Coyle","year":"1986","unstructured":"Coyle, P. K. & Sibony, P. A. Tear immunoglobulins measured by ELISA. Investig. Ophthalmol. Vis. Sci. 27(4), 622\u2013625 (1986).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"31027_CR50","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.2353\/ajpath.2009.090579","volume":"175","author":"VP Saw","year":"2009","unstructured":"Saw, V. P. et al. Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro. Am. J. Pathol. 175(6), 2406\u20132415 (2009).","journal-title":"Am. J. Pathol."},{"issue":"4","key":"31027_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/mi.2010.82","volume":"4","author":"CS De Paiva","year":"2011","unstructured":"De Paiva, C. S. et al. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 4(4), 397\u2013408 (2011).","journal-title":"Mucosal Immunol."},{"issue":"12","key":"31027_CR52","doi-asserted-by":"publisher","first-page":"e0007819","DOI":"10.1371\/journal.pntd.0007819","volume":"13","author":"KJ Rogers","year":"2019","unstructured":"Rogers, K. J. et al. IL-4\/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection. PLoS Negl. Trop. Dis. 13(12), e0007819 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"31027_CR53","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1038\/s41598-020-59976-3","volume":"10","author":"C Woolsey","year":"2020","unstructured":"Woolsey, C. et al. Immune correlates of postexposure vaccine protection against Marburg virus. Sci. Rep. 10(1), 3071 (2020).","journal-title":"Sci. Rep."},{"key":"31027_CR54","doi-asserted-by":"publisher","first-page":"17113","DOI":"10.1038\/nmicrobiol.2017.113","volume":"2","author":"X Zeng","year":"2017","unstructured":"Zeng, X. et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat. Microbiol. 2, 17113 (2017).","journal-title":"Nat. Microbiol."},{"issue":"25","key":"31027_CR55","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","volume":"373","author":"SE Mate","year":"2015","unstructured":"Mate, S. E. et al. Molecular evidence of sexual transmission of Ebola virus. N. Engl. J. Med. 373(25), 2448\u20132454 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"31027_CR56","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13311-016-0457-z","volume":"13","author":"BJ Billioux","year":"2016","unstructured":"Billioux, B. J., Smith, B. & Nath, A. Neurological complications of Ebola virus infection. Neurotherapeutics 13(3), 461\u2013470 (2016).","journal-title":"Neurotherapeutics"},{"issue":"6","key":"31027_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/ICU.0000000000000313","volume":"27","author":"JG Shantha","year":"2016","unstructured":"Shantha, J. G., Yeh, S. & Nguyen, Q. D. Ebola virus disease and the eye. Curr. Opin. Ophthalmol. 27(6), 538\u2013544 (2016).","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"631","key":"31027_CR58","doi-asserted-by":"publisher","first-page":"eabi5229","DOI":"10.1126\/scitranslmed.abi5229","volume":"14","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors. Sci. Transl. Med. 14(631), eabi5229 (2022).","journal-title":"Sci. Transl. Med."},{"key":"31027_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-4939-7116-9_24","volume":"1628","author":"CE Mire","year":"2017","unstructured":"Mire, C. E. & Geisbert, T. W. Evaluation of medical countermeasures against ebolaviruses in nonhuman primate models. Methods Mol. Biol. 1628, 293\u2013307 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"7552","key":"31027_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature14442","volume":"521","author":"EP Thi","year":"2015","unstructured":"Thi, E. P. et al. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature 521(7552), 362\u2013365 (2015).","journal-title":"Nature"},{"issue":"7","key":"31027_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones, S. M. et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11(7), 786\u2013790 (2005).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31027-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31027-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31027-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T15:48:40Z","timestamp":1679845720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31027-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31027"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31027-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.29.474476","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4175"}}